Research & Insights
January 07, 2025
Annual Review of Shareholder Activism 2024
Lazard’s 2024 review of shareholder activism highlights key trends and data in shareholder activism activity throughout the year.
Lazard Global Biopharmaceutical Leaders Study 2024
Biopharmaceutical and biotech investors concluded the summer of 2024 facing ongoing uncertainty.
Lazard Interim Secondary Market Report 2024
Lazard Interim Secondary Market Report 2024